Eli Lilly and Co (LLY)

84.66
0.09 0.11
NYSE : Health Care
Prev Close 84.75
Open 84.62
Day Low/High 84.31 / 84.96
52 Wk Low/High 64.18 / 86.72
Volume 3.06M
Avg Volume 3.52M
Exchange NYSE
Shares Outstanding 1.10B
Market Cap 92.94B
EPS 2.60
P/E Ratio 40.94
Div & Yield 2.08 (2.50%)

Latest News

Cutting Back on Snap-On

We'll sell over half our SNA position after digesting yesterday's results.

5 New Breast Cancer Treatments That Are Helping to Save Lives

5 New Breast Cancer Treatments That Are Helping to Save Lives

In the U.S., one in eight women will be diagnosed with breast cancer in their lifetime; for men, the risk is one in 1,000.

We're Downgrading Snap-On

Despite earnings beat, company is in a 'battleground.'

Exiting This Healthcare Name

We're selling our shares in Walgreens as our bullish thesis has lost its luster.

We're Initiating a Position in a Drug Maker

Bringing Eli Lilly out of the bullpen.

Doing Some Shuffling in the Bullpen

We're adding Nvidia, removing TMO and Six Flags, plus 2 updates.

Valeant Suffers Another Blow After the Approval of Johnson & Johnson's Psoriasis Treatment

Valeant Suffers Another Blow After the Approval of Johnson & Johnson's Psoriasis Treatment

The approval of Johnson & Johnson's psoriasis treatment will have an adverse impact on Valeant in the second half of 2017, Wells Fargo argued.

Cramer: 10 Reasons for Today's Rally

Cramer: 10 Reasons for Today's Rally

Days like this remind you why you stay in.

FDA Cranks Up Its Review of Eli Lilly's Advanced Breast Cancer Drug

FDA Cranks Up Its Review of Eli Lilly's Advanced Breast Cancer Drug

The FDA has given priority review designation for abemaciclib.

Renowned Television Personality Don Francisco Introduces New Initiative To Help Dispel Myths About Diabetes And Insulin Treatment

Renowned Television Personality Don Francisco Introduces New Initiative To Help Dispel Myths About Diabetes And Insulin Treatment

Partnering with Lilly and Boehringer Ingelheim, Don Francisco encourages Hispanic communities to learn the facts about diabetes management

Weekly Roundup

Jobs report and Fed minutes highlight a short week. In the portfolio, we add one name and downgrade another.

UK Supreme Court Rules in Lilly's Favor: Actavis Infringed on European Vitamins Patents

UK Supreme Court Rules in Lilly's Favor: Actavis Infringed on European Vitamins Patents

Lilly sued Actavis, saying its generic product would still infringe on Lilly's vitamin regimens regardless of any dilution.

Lilly And Purdue University Announce Strategic Research Collaboration

Lilly And Purdue University Announce Strategic Research Collaboration

Lilly will provide up to $52 million to fund life science research over five years

Blink Health Giving Away $10 Million Worth Of Free Diabetes Medications

Patients Who Create An Account on Leading Prescription Drug Savings Platform Blink Health Will Receive a Free, One-Year Supply of Three Most Prescribed Generic Type-2 Diabetes Medications: Metformin, Glipizide and Pioglitazone --Until Funds Are Exhausted

Lilly Diabetes Brings An Extra Splash Of Summertime Fun And Inspiration To Diabetes Camps With Launch Of Annual Camp Care Package Speaker Tour

This U.S. diabetes camp support program has provided speakers, scholarships, medicines and educational materials since 2001

Cramer: Stop Talking About the 'Market'

Cramer: Stop Talking About the 'Market'

It just isn't as useful or descriptive right now.

Eli Lilly And Company Unveils Expanded Biotechnology Center In San Diego

New facility and improved technology capabilities part of $850 million U.S. capital investment for 2017

Jim Cramer: Another Rotation Out of Apple and Nvidia Is in the Cards

Jim Cramer: Another Rotation Out of Apple and Nvidia Is in the Cards

We forget that a big hedge fund or mutual fund switching out of tech winners into everything else can roil the market.

On Betting Against the Bonds and Panicking off the Fed: Jim Cramer's Best Blog

On Betting Against the Bonds and Panicking off the Fed: Jim Cramer's Best Blog

Jim Cramer discusses bonds and also talks about why panicking off the Fed is a superbad idea.

Cramer: You Can't Bet Against the Bonds

Cramer: You Can't Bet Against the Bonds

A rotation that started as the minor chord of the rotational symphony and is now the major one.

New Safety And Long-Term Efficacy Data From Baricitinib Clinical Trials In Patients With Moderate-to-Severe Rheumatoid Arthritis Presented At EULAR 2017

- Pooled analysis of eight clinical trials shows no difference in serious infection events compared to placebo